Global Live Herpes Zoster Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The global Live Herpes Zoster Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Live Herpes Zoster Vaccine Industry Forecast” looks at past sales and reviews total world Live Herpes Zoster Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Live Herpes Zoster Vaccine sales for 2024 through 2030. With Live Herpes Zoster Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Herpes Zoster Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Herpes Zoster Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Herpes Zoster Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live Herpes Zoster Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Herpes Zoster Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Herpes Zoster Vaccine.
United States market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Live Herpes Zoster Vaccine players cover Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Herpes Zoster Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Live Herpes Zoster Vaccine market?
What factors are driving Live Herpes Zoster Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Herpes Zoster Vaccine market opportunities vary by end market size?
How does Live Herpes Zoster Vaccine break out by Type, by Application?
Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The global Live Herpes Zoster Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Live Herpes Zoster Vaccine Industry Forecast” looks at past sales and reviews total world Live Herpes Zoster Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Live Herpes Zoster Vaccine sales for 2024 through 2030. With Live Herpes Zoster Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Herpes Zoster Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Herpes Zoster Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Herpes Zoster Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live Herpes Zoster Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Herpes Zoster Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Herpes Zoster Vaccine.
United States market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Live Herpes Zoster Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Live Herpes Zoster Vaccine players cover Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Herpes Zoster Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single-dose Vaccination
- Double-dose Vaccination
- Public Health Sector
- Hospitals & clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- SK
- Changchun BCHT Biotechnology
- SIBP CNBG
What is the 10-year outlook for the global Live Herpes Zoster Vaccine market?
What factors are driving Live Herpes Zoster Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Herpes Zoster Vaccine market opportunities vary by end market size?
How does Live Herpes Zoster Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Herpes Zoster Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Live Herpes Zoster Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Live Herpes Zoster Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Live Herpes Zoster Vaccine Segment by Type
2.2.1 Single-dose Vaccination
2.2.2 Double-dose Vaccination
2.3 Live Herpes Zoster Vaccine Sales by Type
2.3.1 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024)
2.4 Live Herpes Zoster Vaccine Segment by Application
2.4.1 Public Health Sector
2.4.2 Hospitals & clinics
2.4.3 Others
2.5 Live Herpes Zoster Vaccine Sales by Application
2.5.1 Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Live Herpes Zoster Vaccine Breakdown Data by Company
3.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Live Herpes Zoster Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024)
3.2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Live Herpes Zoster Vaccine Sale Price by Company
3.4 Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Herpes Zoster Vaccine Product Location Distribution
3.4.2 Players Live Herpes Zoster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE HERPES ZOSTER VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Herpes Zoster Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Live Herpes Zoster Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Live Herpes Zoster Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Live Herpes Zoster Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Live Herpes Zoster Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Live Herpes Zoster Vaccine Sales Growth
4.4 APAC Live Herpes Zoster Vaccine Sales Growth
4.5 Europe Live Herpes Zoster Vaccine Sales Growth
4.6 Middle East & Africa Live Herpes Zoster Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Herpes Zoster Vaccine Sales by Country
5.1.1 Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024)
5.1.2 Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
5.2 Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024)
5.3 Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Herpes Zoster Vaccine Sales by Region
6.1.1 APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024)
6.1.2 APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024)
6.2 APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024)
6.3 APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Herpes Zoster Vaccine by Country
7.1.1 Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024)
7.1.2 Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
7.2 Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024)
7.3 Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Herpes Zoster Vaccine by Country
8.1.1 Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine
10.3 Manufacturing Process Analysis of Live Herpes Zoster Vaccine
10.4 Industry Chain Structure of Live Herpes Zoster Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Herpes Zoster Vaccine Distributors
11.3 Live Herpes Zoster Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE HERPES ZOSTER VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Herpes Zoster Vaccine Market Size Forecast by Region
12.1.1 Global Live Herpes Zoster Vaccine Forecast by Region (2025-2030)
12.1.2 Global Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Live Herpes Zoster Vaccine Forecast by Type (2025-2030)
12.7 Global Live Herpes Zoster Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 SK
13.3.1 SK Company Information
13.3.2 SK Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SK Main Business Overview
13.3.5 SK Latest Developments
13.4 Changchun BCHT Biotechnology
13.4.1 Changchun BCHT Biotechnology Company Information
13.4.2 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Changchun BCHT Biotechnology Main Business Overview
13.4.5 Changchun BCHT Biotechnology Latest Developments
13.5 SIBP CNBG
13.5.1 SIBP CNBG Company Information
13.5.2 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SIBP CNBG Main Business Overview
13.5.5 SIBP CNBG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Herpes Zoster Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Live Herpes Zoster Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Live Herpes Zoster Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Live Herpes Zoster Vaccine Segment by Type
2.2.1 Single-dose Vaccination
2.2.2 Double-dose Vaccination
2.3 Live Herpes Zoster Vaccine Sales by Type
2.3.1 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024)
2.4 Live Herpes Zoster Vaccine Segment by Application
2.4.1 Public Health Sector
2.4.2 Hospitals & clinics
2.4.3 Others
2.5 Live Herpes Zoster Vaccine Sales by Application
2.5.1 Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Live Herpes Zoster Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Live Herpes Zoster Vaccine Breakdown Data by Company
3.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Live Herpes Zoster Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024)
3.2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Live Herpes Zoster Vaccine Sale Price by Company
3.4 Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Herpes Zoster Vaccine Product Location Distribution
3.4.2 Players Live Herpes Zoster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE HERPES ZOSTER VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Herpes Zoster Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Live Herpes Zoster Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Live Herpes Zoster Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Live Herpes Zoster Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Live Herpes Zoster Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Live Herpes Zoster Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Live Herpes Zoster Vaccine Sales Growth
4.4 APAC Live Herpes Zoster Vaccine Sales Growth
4.5 Europe Live Herpes Zoster Vaccine Sales Growth
4.6 Middle East & Africa Live Herpes Zoster Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Herpes Zoster Vaccine Sales by Country
5.1.1 Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024)
5.1.2 Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
5.2 Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024)
5.3 Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Herpes Zoster Vaccine Sales by Region
6.1.1 APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024)
6.1.2 APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024)
6.2 APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024)
6.3 APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Herpes Zoster Vaccine by Country
7.1.1 Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024)
7.1.2 Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
7.2 Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024)
7.3 Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Herpes Zoster Vaccine by Country
8.1.1 Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Live Herpes Zoster Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine
10.3 Manufacturing Process Analysis of Live Herpes Zoster Vaccine
10.4 Industry Chain Structure of Live Herpes Zoster Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Herpes Zoster Vaccine Distributors
11.3 Live Herpes Zoster Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE HERPES ZOSTER VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Herpes Zoster Vaccine Market Size Forecast by Region
12.1.1 Global Live Herpes Zoster Vaccine Forecast by Region (2025-2030)
12.1.2 Global Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Live Herpes Zoster Vaccine Forecast by Type (2025-2030)
12.7 Global Live Herpes Zoster Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 SK
13.3.1 SK Company Information
13.3.2 SK Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SK Main Business Overview
13.3.5 SK Latest Developments
13.4 Changchun BCHT Biotechnology
13.4.1 Changchun BCHT Biotechnology Company Information
13.4.2 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Changchun BCHT Biotechnology Main Business Overview
13.4.5 Changchun BCHT Biotechnology Latest Developments
13.5 SIBP CNBG
13.5.1 SIBP CNBG Company Information
13.5.2 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications
13.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SIBP CNBG Main Business Overview
13.5.5 SIBP CNBG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Herpes Zoster Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Live Herpes Zoster Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single-dose Vaccination
Table 4. Major Players of Double-dose Vaccination
Table 5. Global Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Live Herpes Zoster Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Live Herpes Zoster Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Live Herpes Zoster Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Live Herpes Zoster Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Live Herpes Zoster Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live Herpes Zoster Vaccine Products Offered
Table 22. Live Herpes Zoster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Herpes Zoster Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Live Herpes Zoster Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Live Herpes Zoster Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Live Herpes Zoster Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Live Herpes Zoster Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Live Herpes Zoster Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Live Herpes Zoster Vaccine
Table 52. Key Market Challenges & Risks of Live Herpes Zoster Vaccine
Table 53. Key Industry Trends of Live Herpes Zoster Vaccine
Table 54. Live Herpes Zoster Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Herpes Zoster Vaccine Distributors List
Table 57. Live Herpes Zoster Vaccine Customer List
Table 58. Global Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Live Herpes Zoster Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Live Herpes Zoster Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Live Herpes Zoster Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Live Herpes Zoster Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Live Herpes Zoster Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Live Herpes Zoster Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 74. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 79. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. SK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. SK Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 84. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. SK Main Business
Table 86. SK Latest Developments
Table 87. Changchun BCHT Biotechnology Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 89. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Changchun BCHT Biotechnology Main Business
Table 91. Changchun BCHT Biotechnology Latest Developments
Table 92. SIBP CNBG Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 94. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. SIBP CNBG Main Business
Table 96. SIBP CNBG Latest Developments
Table 1. Live Herpes Zoster Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Live Herpes Zoster Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single-dose Vaccination
Table 4. Major Players of Double-dose Vaccination
Table 5. Global Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Live Herpes Zoster Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Live Herpes Zoster Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Live Herpes Zoster Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Live Herpes Zoster Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Live Herpes Zoster Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Live Herpes Zoster Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Live Herpes Zoster Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Live Herpes Zoster Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Live Herpes Zoster Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Live Herpes Zoster Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Live Herpes Zoster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live Herpes Zoster Vaccine Products Offered
Table 22. Live Herpes Zoster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Herpes Zoster Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Live Herpes Zoster Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Live Herpes Zoster Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Live Herpes Zoster Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Live Herpes Zoster Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Live Herpes Zoster Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Live Herpes Zoster Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Live Herpes Zoster Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Live Herpes Zoster Vaccine
Table 52. Key Market Challenges & Risks of Live Herpes Zoster Vaccine
Table 53. Key Industry Trends of Live Herpes Zoster Vaccine
Table 54. Live Herpes Zoster Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Herpes Zoster Vaccine Distributors List
Table 57. Live Herpes Zoster Vaccine Customer List
Table 58. Global Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Live Herpes Zoster Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Live Herpes Zoster Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Live Herpes Zoster Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Live Herpes Zoster Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Live Herpes Zoster Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Live Herpes Zoster Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Live Herpes Zoster Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Live Herpes Zoster Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Live Herpes Zoster Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 74. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 79. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. SK Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. SK Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 84. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. SK Main Business
Table 86. SK Latest Developments
Table 87. Changchun BCHT Biotechnology Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 89. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Changchun BCHT Biotechnology Main Business
Table 91. Changchun BCHT Biotechnology Latest Developments
Table 92. SIBP CNBG Basic Information, Live Herpes Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product Portfolios and Specifications
Table 94. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. SIBP CNBG Main Business
Table 96. SIBP CNBG Latest Developments
LIST OF FIGURES
Figure 1. Picture of Live Herpes Zoster Vaccine
Figure 2. Live Herpes Zoster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Herpes Zoster Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Live Herpes Zoster Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Live Herpes Zoster Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Single-dose Vaccination
Figure 12. Product Picture of Double-dose Vaccination
Figure 13. Global Live Herpes Zoster Vaccine Sales Market Share by Type in 2023
Figure 14. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Live Herpes Zoster Vaccine Consumed in Public Health Sector
Figure 16. Global Live Herpes Zoster Vaccine Market: Public Health Sector (2019-2024) & (K Dose)
Figure 17. Live Herpes Zoster Vaccine Consumed in Hospitals & clinics
Figure 18. Global Live Herpes Zoster Vaccine Market: Hospitals & clinics (2019-2024) & (K Dose)
Figure 19. Live Herpes Zoster Vaccine Consumed in Others
Figure 20. Global Live Herpes Zoster Vaccine Market: Others (2019-2024) & (K Dose)
Figure 21. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2023)
Figure 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Application in 2023
Figure 23. Live Herpes Zoster Vaccine Sales by Company in 2023 (K Dose)
Figure 24. Global Live Herpes Zoster Vaccine Sales Market Share by Company in 2023
Figure 25. Live Herpes Zoster Vaccine Revenue by Company in 2023 ($ millions)
Figure 26. Global Live Herpes Zoster Vaccine Revenue Market Share by Company in 2023
Figure 27. Global Live Herpes Zoster Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 30. Americas Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 31. APAC Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 32. APAC Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Europe Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 34. Europe Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 36. Middle East & Africa Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 37. Americas Live Herpes Zoster Vaccine Sales Market Share by Country in 2023
Figure 38. Americas Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Figure 39. Americas Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 40. Americas Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 41. United States Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Live Herpes Zoster Vaccine Sales Market Share by Region in 2023
Figure 46. APAC Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2024)
Figure 47. APAC Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 48. APAC Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 49. China Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. India Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Live Herpes Zoster Vaccine Sales Market Share by Country in 2023
Figure 57. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Figure 58. Europe Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 59. Europe Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 60. Germany Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. France Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine in 2023
Figure 74. Manufacturing Process Analysis of Live Herpes Zoster Vaccine
Figure 75. Industry Chain Structure of Live Herpes Zoster Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Live Herpes Zoster Vaccine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Live Herpes Zoster Vaccine
Figure 2. Live Herpes Zoster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Herpes Zoster Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Live Herpes Zoster Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Live Herpes Zoster Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Live Herpes Zoster Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Single-dose Vaccination
Figure 12. Product Picture of Double-dose Vaccination
Figure 13. Global Live Herpes Zoster Vaccine Sales Market Share by Type in 2023
Figure 14. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Live Herpes Zoster Vaccine Consumed in Public Health Sector
Figure 16. Global Live Herpes Zoster Vaccine Market: Public Health Sector (2019-2024) & (K Dose)
Figure 17. Live Herpes Zoster Vaccine Consumed in Hospitals & clinics
Figure 18. Global Live Herpes Zoster Vaccine Market: Hospitals & clinics (2019-2024) & (K Dose)
Figure 19. Live Herpes Zoster Vaccine Consumed in Others
Figure 20. Global Live Herpes Zoster Vaccine Market: Others (2019-2024) & (K Dose)
Figure 21. Global Live Herpes Zoster Vaccine Sale Market Share by Application (2023)
Figure 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Application in 2023
Figure 23. Live Herpes Zoster Vaccine Sales by Company in 2023 (K Dose)
Figure 24. Global Live Herpes Zoster Vaccine Sales Market Share by Company in 2023
Figure 25. Live Herpes Zoster Vaccine Revenue by Company in 2023 ($ millions)
Figure 26. Global Live Herpes Zoster Vaccine Revenue Market Share by Company in 2023
Figure 27. Global Live Herpes Zoster Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Live Herpes Zoster Vaccine Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 30. Americas Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 31. APAC Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 32. APAC Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Europe Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 34. Europe Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Live Herpes Zoster Vaccine Sales 2019-2024 (K Dose)
Figure 36. Middle East & Africa Live Herpes Zoster Vaccine Revenue 2019-2024 ($ millions)
Figure 37. Americas Live Herpes Zoster Vaccine Sales Market Share by Country in 2023
Figure 38. Americas Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Figure 39. Americas Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 40. Americas Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 41. United States Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Live Herpes Zoster Vaccine Sales Market Share by Region in 2023
Figure 46. APAC Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2024)
Figure 47. APAC Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 48. APAC Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 49. China Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. India Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Live Herpes Zoster Vaccine Sales Market Share by Country in 2023
Figure 57. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Figure 58. Europe Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 59. Europe Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 60. Germany Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. France Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Live Herpes Zoster Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Live Herpes Zoster Vaccine in 2023
Figure 74. Manufacturing Process Analysis of Live Herpes Zoster Vaccine
Figure 75. Industry Chain Structure of Live Herpes Zoster Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Live Herpes Zoster Vaccine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Live Herpes Zoster Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Live Herpes Zoster Vaccine Revenue Market Share Forecast by Application (2025-2030)
